• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].

作者信息

Sekhar K V G Chandra, Rao V S, Devambatla Ravi Kumar Vyas, Kumar M Murali Krishna

机构信息

Chemistry Group, Birla Institute of Technology & Science, FDIII, Vidya Vihar, Pilani, Rajasthan 333 031, India.

Chemistry Group, Birla Institute of Technology & Science, FDIII, Vidya Vihar, Pilani, Rajasthan 333 031, India.

出版信息

Bioorg Med Chem Lett. 2017 May 1;27(9):2081. doi: 10.1016/j.bmcl.2017.02.064. Epub 2017 Mar 20.

DOI:10.1016/j.bmcl.2017.02.064
PMID:28336140
Abstract
摘要

相似文献

1
Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
Bioorg Med Chem Lett. 2017 May 1;27(9):2081. doi: 10.1016/j.bmcl.2017.02.064. Epub 2017 Mar 20.
2
Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents.新型非典型抗精神病药物N-2-(4-(4-(2-取代噻唑-4-基)哌嗪-1-基)-2-氧代乙基)乙酰胺的合成及初步药理学评价
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6054-7. doi: 10.1016/j.bmcl.2008.10.035. Epub 2008 Oct 11.
3
Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents.新型 N-{2-[4-(取代)哌嗪-1-基]-2-氧代乙基}乙酰胺的合成与初步筛选作为潜在的非典型抗精神病药物。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):871-5. doi: 10.1080/14756360802447750.
4
Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].《“1-噻唑-2-基-N-3-甲基-1H-吡唑-5-羧酸衍生物作为抗肿瘤剂”的勘误》[《生物有机与药物化学快报》27 (2017) 4471 - 4477]
Bioorg Med Chem Lett. 2018 Mar 1;28(5):985. doi: 10.1016/j.bmcl.2018.01.046. Epub 2018 Feb 9.
5
Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics.2-[4-(芳基取代)哌嗪-1-基]N,N-二苯基乙酰胺的合成、计算研究及初步药理学评价作为潜在的抗精神病药物。
Eur J Med Chem. 2011 Sep;46(9):4753-9. doi: 10.1016/j.ejmech.2011.07.028. Epub 2011 Jul 22.
6
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
7
Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].《查耳酮衍生物作为抗炎剂的设计、合成、生物学评价及分子对接》的勘误 [《生物有机与药物化学快报》27 (3) (2017) 602 - 606]
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3822. doi: 10.1016/j.bmcl.2018.10.027. Epub 2018 Oct 30.
8
Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].《新型查尔酮取代苯磺酰胺的合成及其碳酸酐酶抑制活性》的勘误 [《生物有机与药物化学快报》26 (2016) 5867 - 5870]
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3944. doi: 10.1016/j.bmcl.2017.02.074. Epub 2017 Jul 10.
9
Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476].《(1,2-二氢萘并[2,1-b]呋喃-2-基)甲酮衍生物的抗癌潜力》勘误 [《生物有机与药物化学快报》30 (2020) 127476]
Bioorg Med Chem Lett. 2021 Feb 15;34:127764. doi: 10.1016/j.bmcl.2020.127764. Epub 2021 Jan 2.
10
Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].《通过三组分反应合成新型抗癌钌-芳烃吡啶基亚甲基支架》的勘误 [《生物有机与药物化学快报》26 (2016) 2695-2700]
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4154-4155. doi: 10.1016/j.bmcl.2016.06.069.